Impfen Pro & Contra - Das Handbuch für die individuelle Impfentscheidung

media. N Engl J Med 2001, 344 (6): 403–409
    ESPED (Erhebungseinheit für seltene pädiatrische Erkrankungen in Deutschland): Jahresbericht 2010. http:// www.esped.uni-duesseldorf.de/jabe2010.pdf (Zugriff 16. 12. 2011)
    Esposito, A. L.: Aspirin impairs antibacterial mechanisms in experimental pneumococcal pneumonia. Am Rev Respir Dis 1984, 130 (5): 857–862
    FR (Frankfurter Rundschau) Online: Impfung kann Babys gefährlich werden. 7.9.2010
    French, N., Nakiyingi, J., Carpenter, L. M., Lugada, E., et al.: 23-valent pneumococcal polysaccharide vaccine in HIV -1-infected Ugandan adults: double-blind, randomised and placebo controlled trial. Lancet 2000, 355 (9221): 2106–2111
    Gils, E. J. van, Veenhoven, R. H., Rodenburg, G. D., Hak, E., Sanders, E. A.: Effect of 7-valent pneumococcal conjugate vaccine on nasopharyngeal carriage with Haemophilus influenzae and Moraxella catarrhalis in a randomized controlled trial. Vaccine 2011a, 29 (44): 7595–7598
    Gils, E. J. van, Hak, E., Veenhoven, R. H., Rodenburg, G. D., et al.: Effect of seven-valent pneumococcal conjugate vaccine on Staphylococcus aureus colonisation in a randomised controlled trial. PL oS One 2011b, 6 (6): e20229
    Goldblatt, D., et al.: Immunogenicity and boosting after a reduced number of doses of a pneumococcal conjugate vaccine in infants and toddlers. Pediatr Infect Dis J 2006; 25: 312–319
    Golubchik, T., Brueggemann, A. B., Street, T., Gertz jr., R. E.: Pneumococcal genome sequencing tracks a vaccine escape variant formed through a multi-fragment recombination event. Nat Genet 2012, 44 (3): 352–355
    Gonzalez, B. E., Hulten, K. G., Lamberth, L., Kaplan, S. L.: Streptococcus pneumoniae serogroups 15 and 33: an increasing cause of pneumococcal infections in children in the United States after the introduction of the pneumococcal 7-valent conjugate vaccine. Pediatr Infect Dis J 2006, 25 (4): 301–305
    Hochmann, M. E.: Childhood vaccine saves lives, but may lead to other infections. The Boston Globe 21.6.2005. http:// www.boston.com/news/globe/health_science/articles/2005/06/21/childhood_vaccine_saves_lives_but_may_lead_to_other_infections/?page=1 (Zugriff 16. 12. 2011)
    Honkanen, P. O., Keistinen, T., Miettinen, L., Herva, E., et al.: Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older. Vaccine 1999, 4; 17 (20–21): 2493–2500
    Huss, A., Scott, P., Stuck, A. E., Trotter, C., Egger, M.: Efficacy of pneumococcal vaccination in adults: a meta-analysis. CMAJ 2009, 180 (1): 48–58
    Jackson, L. A.: Effectiveness of pneumococcal polysaccharide vaccine in older adults. N Engl J Med 2003, 348: 1747–1755
    JCVI (Joint Committee for Vaccination and Immunization): JCVI statement on discontinuation of the routine pneumococcal vaccination programme for adults aged 65 years and older. 16.3.2011. http:// www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@ab/documents/digitalasset/dh_125122.pdf (Zugriff 14. 12. 2011)
    Jefferies, S., Weatherall, M., Young, P., Eyers, S., Beasley, R.: Systematic review and meta-analysis of the effects of antipyretic medications on mortality in Streptococcus pneumoniae infections. Postgrad Med J 2012, 88 (1035): 21–27
    Kenzel, S., Hufnagel, M., et al.: Pneumokokkenimpfung und Serotype-Replacement: Brauchen wir ein neues Impf(stoff)konzept? Dtsch Med Wochenschr 2010, 135: 1198–1200
    Korona-Glowniak, I., Niedzielski, A., Malm, A.: Upper respiratory colonization by Streptococcus pneumoniae in healthy pre-school children in south-east Poland. Int J Pediatr Otorhinolaryngol 2011, 75 (12): 1529–1534
    Kries, R. von, Siedler, A., Schmitt, H. J.: Epidemiologie von Pneumokokken-Infektionen bei Kindern. Kinderärztl Prax 2000, 71: 435–438
    Lakshman, R., Murdoch, C., Race, G., Burkinshaw, R., et al.: Pneumococcal nasopharyngeal carriage in children following heptavalent pneumococcal conjugate vaccination in infancy. Arch Dis Child 2003, 88 (3): 211–214
    Laurance, J.: Increase in severe pneumonia in children may be caused by vaccine. The Indipendent 14.4.2008
    Lepoutre, A., Varon, E., Georges, S., Gutmann, L.: Impact of infant pneumococcal vaccination on invasive pneumococcal diseases in France 2001–2006. Eurosurveillance 2008, 35
    Levine, O. S., Farley, M., Harrison, L. H., Lefkowitz, L., et al.: Risk factors for invasive pneumococcal disease in children: a